Search Results - "Fallacara, Anna Lucia"

Refine Results
  1. 1

    An Update on JAK Inhibitors by Musumeci, Francesca, Greco, Chiara, Giacchello, Ilaria, Fallacara, Anna Lucia, Ibrahim, Munjed M, Grossi, Giancarlo, Brullo, Chiara, Schenone, Silvia

    Published in Current medicinal chemistry (01-01-2019)
    “…Janus kinases (JAKs) are a family of non-receptor tyrosine kinases, composed by four members, JAK1, JAK2, JAK3 and TYK2. JAKs are involved in different…”
    Get more information
    Journal Article
  2. 2

    Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors by Musumeci, Francesca, Sanna, Monica, Grossi, Giancarlo, Brullo, Chiara, Fallacara, Anna Lucia, Schenone, Silvia

    Published in Current medicinal chemistry (01-06-2017)
    “…The pyrrolo[2,3-d]pyrimidine nucleus is a deaza-isostere of adenine, the nitrogenous base of ATP, and is present in many ATP-competitive inhibitors of…”
    Get more information
    Journal Article
  3. 3

    Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors by Francini, Cinzia Maria, Musumeci, Francesca, Fallacara, Anna Lucia, Botta, Lorenzo, Molinari, Alessio, Artusi, Roberto, Mennuni, Laura, Angelucci, Adriano, Schenone, Silvia

    Published in Molecules (Basel, Switzerland) (17-09-2018)
    “…Protein kinases have emerged as crucial targets for cancer therapy over the last decades. Since 2001, 40 and 39 kinase inhibitors have been approved by FDA and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Probing the Binding Site of Abl Tyrosine Kinase Using in Situ Click Chemistry by Peruzzotti, Cristina, Borrelli, Stella, Ventura, Micol, Pantano, Rebecca, Fumagalli, Gaia, Christodoulou, Michael S, Monticelli, Damiano, Luzzani, Marcello, Fallacara, Anna Lucia, Tintori, Cristina, Botta, Maurizio, Passarella, Daniele

    Published in ACS medicinal chemistry letters (14-02-2013)
    “…Modern combinatorial chemistry is used to discover compounds with desired function by an alternative strategy, in which the biological target is directly…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Abstract 2201: Preclinical development of novel pyrazolo[3,4- d ]pyrimidines structure-based TKIs for the treatment of glioblastoma by Mancini, Arianna, Fallacara, Anna Lucia, Zamperini, Claudio, Iovenitti, Giulia, Molinari, Alessio, Rango, Enrico, Angelucci, Adriano, Schenone, Silvia, Botta, Maurizio

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract The aim of this study was the preclinical development of a set of pyrazolo[3,4-d]pyrimidine structure-based small molecules ATP-competitive SRC…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction by Tintori, Cristina, Laurenzana, Ilaria, Fallacara, Anna Lucia, Kessler, Ulrich, Pilger, Beatrice, Stergiou, Lilli, Botta, Maurizio

    Published in Bioorganic & medicinal chemistry letters (01-01-2014)
    “…A high-throughput molecular docking approach was successfully applied for the selection of potential inhibitors of the Influenza RNA-polymerase which act by…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Protein–protein interactions and human cellular cofactors as new targets for HIV therapy by Tintori, Cristina, Brai, Annalaura, Fallacara, Anna Lucia, Fazi, Roberta, Schenone, Silvia, Botta, Maurizio

    Published in Current opinion in pharmacology (01-10-2014)
    “…Highlights • Insight into new strategies in HIV therapy. • Targeting protein–protein interactions in HIV. • Targeting cellular cofactors in HIV…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Insight into the Allosteric Inhibition of Abl Kinase by Fallacara, Anna Lucia, Tintori, Cristina, Radi, Marco, Schenone, Silvia, Botta, Maurizio

    “…Abl kinase inhibitors targeting the ATP binding pocket are currently used as a front-line therapy for the treatment of chronic myelogenous leukemia (CML), but…”
    Get full text
    Journal Article
  19. 19

    Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors by Musumeci, Francesca, Sanna, Monica, Greco, Chiara, Giacchello, Ilaria, Fallacara, Anna Lucia, Amato, Rosario, Schenone, Silvia

    Published in Expert opinion on therapeutic patents (02-12-2017)
    “…Btk is a tyrosine kinase dysregulated in several B-cell malignancies and autoimmune diseases, and this has given rise to a search for Btk inhibitors…”
    Get more information
    Journal Article
  20. 20